chr15-33866065-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_001036.6(RYR3):c.*839A>G variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.615 in 154,892 control chromosomes in the GnomAD database, including 31,527 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.61 ( 30745 hom., cov: 32)
Exomes 𝑓: 0.73 ( 782 hom. )
Consequence
RYR3
NM_001036.6 3_prime_UTR
NM_001036.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.91
Publications
42 publications found
Genes affected
RYR3 (HGNC:10485): (ryanodine receptor 3) The protein encoded by this gene is a ryanodine receptor, which functions to release calcium from intracellular storage for use in many cellular processes. For example, the encoded protein is involved in skeletal muscle contraction by releasing calcium from the sarcoplasmic reticulum followed by depolarization of T-tubules. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 15-33866065-A-G is Benign according to our data. Variant chr15-33866065-A-G is described in ClinVar as Benign. ClinVar VariationId is 706987.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.739 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.613 AC: 93121AN: 151898Hom.: 30745 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
93121
AN:
151898
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.726 AC: 2086AN: 2874Hom.: 782 Cov.: 0 AF XY: 0.723 AC XY: 1114AN XY: 1540 show subpopulations
GnomAD4 exome
AF:
AC:
2086
AN:
2874
Hom.:
Cov.:
0
AF XY:
AC XY:
1114
AN XY:
1540
show subpopulations
African (AFR)
AF:
AC:
7
AN:
18
American (AMR)
AF:
AC:
412
AN:
552
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
12
East Asian (EAS)
AF:
AC:
20
AN:
34
South Asian (SAS)
AF:
AC:
102
AN:
178
European-Finnish (FIN)
AF:
AC:
316
AN:
432
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
1156
AN:
1544
Other (OTH)
AF:
AC:
68
AN:
104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.524
Heterozygous variant carriers
0
27
55
82
110
137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.613 AC: 93135AN: 152018Hom.: 30745 Cov.: 32 AF XY: 0.613 AC XY: 45542AN XY: 74318 show subpopulations
GnomAD4 genome
AF:
AC:
93135
AN:
152018
Hom.:
Cov.:
32
AF XY:
AC XY:
45542
AN XY:
74318
show subpopulations
African (AFR)
AF:
AC:
14574
AN:
41414
American (AMR)
AF:
AC:
10810
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
2220
AN:
3472
East Asian (EAS)
AF:
AC:
2334
AN:
5168
South Asian (SAS)
AF:
AC:
2731
AN:
4824
European-Finnish (FIN)
AF:
AC:
7669
AN:
10578
Middle Eastern (MID)
AF:
AC:
162
AN:
292
European-Non Finnish (NFE)
AF:
AC:
50621
AN:
67976
Other (OTH)
AF:
AC:
1317
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1659
3319
4978
6638
8297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
758
1516
2274
3032
3790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1729
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Epileptic encephalopathy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.